ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2016

OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales.

Nick Freemantle et al.PubMed ↗Publisher ↗

No numbers read from the abstract.